{"id":5389,"date":"2025-07-17T23:02:53","date_gmt":"2025-07-17T23:02:53","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/07\/17\/ultragenyx-rare-disease-drug-rejected-fda-sarepta-layoffs-readout-loud-podcast\/"},"modified":"2025-07-17T23:02:53","modified_gmt":"2025-07-17T23:02:53","slug":"ultragenyx-rare-disease-drug-rejected-fda-sarepta-layoffs-readout-loud-podcast","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/07\/17\/ultragenyx-rare-disease-drug-rejected-fda-sarepta-layoffs-readout-loud-podcast\/","title":{"rendered":"Inside an FDA drug rejection, and layoffs at Sarepta"},"content":{"rendered":"<p>    Inside an FDA drug rejection, and layoffs at Sarepta<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Just how many employees is Sarepta Therapeutics laying off? And why did the Food and Drug Administration reject Ultragenyx\u2019s rare disease drug over manufacturing qualms?<\/p>\n<p>We discuss all that and more on this week\u2019s episode of \u201cThe Readout LOUD\u201d. <\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/07\/17\/ultragenyx-rare-disease-drug-rejected-fda-sarepta-layoffs-readout-loud-podcast\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Allison DeAngelis, Adam Feuerstein, and Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/07\/17\/ultragenyx-rare-disease-drug-rejected-fda-sarepta-layoffs-readout-loud-podcast\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Inside an FDA drug rejection, and layoffs at Sarepta Just how many employees is Sarepta Therapeutics laying off? And why did the Food and Drug Administration reject Ultragenyx\u2019s rare disease drug over manufacturing qualms? We discuss all that and more on this week\u2019s episode of \u201cThe Readout LOUD\u201d. Read the rest\u2026 Allison DeAngelis, Adam Feuerstein, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2146,2155,2678,2265],"tags":[2150],"class_list":["post-5389","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-fda","category-pharmaceuticals","category-rare-diseases","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5389"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=5389"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/5389\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=5389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=5389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=5389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}